Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid symbols : SNY save search
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 20.4%
H: 26.64%
C: 6.13%
covid vaccine positive influenza topline results show
Global Biopharmaceutical Contract Manufacturing Markets, 2022-2027: Surge in Manufacturing Capacity Expansion Post Covid by CDMOs and CMOs
Published: 2022-09-01 (Crawled : 21:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
expansion global covid contract capacity
Regeneron Overcomes Loss of COVID Antibody to Post Positive First Quarter
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -3.68%
H: 0.0%
C: 0.0%
covid antibody positive
Clinical Catch-Up: COVID-19, AAN, ACC
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: -0.32%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 4.5%
H: 0.0%
C: 0.0%
covid-19 covid
Pfizer Boss Earned $24.3 Million in 2021 and Other COVID-19 News
Published: 2022-03-21 (Crawled : 15:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 4.78%
H: 0.0%
C: -5.78%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
covid-19 covid
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Published: 2022-03-17 (Crawled : 13:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
covid-19 covid bioscience vaccine
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | $86.3 -1.81% -1.84% 780K
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -1.99%
H: 2.84%
C: 0.35%
MRNA S | $103.81 -0.05% -0.05% 2.2M
|
Health Technology
|
| O: -2.09%
H: 0.95%
C: 0.01%
covid-19 research covid vaccine
Sanofi and GSK Prepare to Submit COVID-19 Vaccine as Cases Fall
Published: 2022-02-23 (Crawled : 16:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
covid-19 covid vaccine
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
Published: 2022-02-23 (Crawled : 11:00) - globenewswire.com
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
covid-19 covid authorization vaccine
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published: 2022-02-10 (Crawled : 12:00) - prnewswire.com
LZAGF | $577.676 -19.1% 25
|
Health Technology
|
| O: -1.72%
H: 0.46%
C: -0.51%
LZAGY | $58.05 0.02% 27K
|
Professional, Scientific, and T...
|
| O: -1.31%
H: 2.63%
C: 0.75%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $41.585 0.08% 0.08% 1.1M
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -2.42%
H: 0.49%
C: -2.63%
covid-19 application covid services growing
Sidelined Regeneron COVID-19 Therapy Drove 2021 Revenue
Published: 2022-02-04 (Crawled : 21:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
covid-19 covid therapy
Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published: 2022-02-02 (Crawled : 21:00) - prnewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -4.8%
H: 4.69%
C: -0.33%
MRNA S | $103.81 -0.05% -0.05% 2.2M
|
Health Technology
|
| O: -3.66%
H: 3.05%
C: -0.68%
covid-19 covid report vaccine
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
XNCR | $18.94 -5.82% -6.18% 500K
|
Health Technology
|
| O: 0.38%
H: 1.12%
C: -1.31%
VIR | $8.36 -2.45% -2.51% 660K
|
Health Technology
|
| O: 1.05%
H: 1.98%
C: -6.88%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
covid-19 treatment fda application covid authorization merge emergency use authorization
7MM COVID-19 Vaccines Market Outlook 2021-2026 incl. an Excel Model w/ Patient-based Sales Forecasts
Published: 2022-01-13 (Crawled : 15:30) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
covid-19 sales covid cel vaccine
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Published: 2022-01-03 (Crawled : 18:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: -0.93%
H: 0.09%
C: -3.16%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
BNTX | $86.3 -1.81% -1.84% 780K
|
Health Technology
|
| O: -1.52%
H: 0.89%
C: -8.67%
covid-19 fda als covid authorization vaccine merge order emergency use authorization
BiondVax signs definitive agreements for development and commercialization of innovative nanosized COVID-19 antibody therapy with Max Planck Institute of Biophysical Chemistry and University Medical Center Göttingen, Germany
Published: 2021-12-22 (Crawled : 12:30) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.59%
H: 1.12%
C: 0.93%
covid-19 commercialization covid germany therapy antibody
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.36%
H: 0.46%
C: 0.46%
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
XNCR | $18.94 -5.82% -6.18% 500K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
VIR | $8.36 -2.45% -2.51% 660K
|
Health Technology
|
| O: -4.59%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
covid-19 treatment europe granted covid authorization grant
Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation
Published: 2021-12-15 (Crawled : 07:00) - globenewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 4.76%
H: 2.5%
C: 2.5%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
covid-19 trial covid positive vaccine phase 3
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea
Published: 2021-12-14 (Crawled : 07:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
CTLT | $55.78 -0.53% 0.0% 1.3M
|
Health Technology
|
| O: 0.26%
H: 0.44%
C: -0.68%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
MRNA S | $103.81 -0.05% -0.05% 2.2M
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
covid-19 drug covid food authorization vaccine
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.